Microscopy & Imaging

New scanning method creates whole-body “atlases” of biological systems

By Matt Limb

wildDISCO can create whole-body “atlases” focusing on the nervous system, lymphatic vessels, blood vessels, and immune cells to highlight normal structures and tumors in early stages of formation.

July 13, 2023

Convert a smartphone into a fluorescent microscope for under $50

By Elissa Wolfson

Researchers inexpensively convert smartphones into what they describe as “glowscope” microscopes, potentially enabling underserved students to observe living organisms.

March 9, 2023

Self-supervised deep learning algorithm shows promise for rapid whole-slide-imaging retrieval

By Jared Berberabe

Brigham and Women’s Hospital researchers are developing an algorithm to speed whole-slide-imaging retrieval from large digital repositories.

October 19, 2022

Zeiss, Ultivue to co-market spatial phenomics solution

By LabPulse.com staff writers

The partners will provide a streamlined solution for processes from tissue preparation to image acquisition and analysis for applications in cancer biology, immunology, and drug development, Zeiss said.

October 12, 2022

Does Tc-99m SPECT damage DNA?

By Will Morton

In a pilot study, researchers studied the effect of ionizing radiation on patients who underwent MPI exams, also known as nuclear stress tests. They used a comet assay, a standard lab test for detecting DNA damage in cells, to analyze patient blood samples before and after they underwent imaging, with results suggesting a small yet likely irrelevant amount of damage.

September 19, 2022

Boosted by COVID-19 and cancer tests, IVD market reaches $127B: Kalorama

By Bruce Carlson

That's the finding from Kalorama's market research report, The Worldwide Market for In Vitro Diagnostics, 15th edition.

August 25, 2022

Decline in COVID tests pulls down Q3 revenue at Siemens Healthineers

By LabPulse.com staff writers

For the quarter (end-June 30), Siemens Healthineers posted third-quarter revenues of 5.186 billion euros ($5.25 billion), down 5.7% after currency adjustment compared with revenues of 5 billion euros ($5.07 billion) the year before. The company's net income for the quarter was 364 million euros ($369 million), down 8% compared with net income of 395 million euros ($400 million) in the same quarter the year before.

August 2, 2022

Beckman, Scopio to partner on blood smear platforms

By LabPulse.com staff writers

Scopio's technology employs full-field imaging and artificial intelligence (AI) decision support with the aim of eliminating manual microscopy. The platform allows full-field images to be shared in real-time over a secure hospital network and captures large scan areas at 100X magnification.

July 19, 2022

Etiometry, Radiometer partner to enhance NICU workflows

By LabPulse.com staff writers

The partnership pairs Etiometry's platform for creating holistic views across the patient care continuum with Radiometer's transcutaneous monitoring (TCM) system for monitoring ventilation of neonatal patients.

June 29, 2022

3D microscope may replace biopsies with real-time imaging

By Leah Sherwood

The system, called MediSCAPE (Swept Confocally Aligned Planar Excitation microscopy), is capable of capturing images of tissue structures that can guide surgeons to navigate tumors and their boundaries without needing to remove tissues and wait for pathology results. If proven in the field, the technology could eventually replace conventional biopsies and histology with real-time imaging within the living body.

March 28, 2022

PathAI, Cleveland Clinic to build pathology research infrastructure

By LabPulse.com staff writers

The collaboration will combine PathAI's artificial intelligence (AI)-based platforms with Cleveland Clinic's clinical expertise and multimodal data to implement next-generation pathology diagnostics, PathAI said in a news release.

March 9, 2022

Insightec to launch new trials of Exablate Neuro

By LabPulse.com staff writers

One study will evaluate the use of Exablate Neuro to treat patients with primary non-small cell lung cancer that has metastasized to the brain in conjunction with Keytruda, a humanized antibody immunotherapy. Exablate Neuro could be used to open up the blood-brain barrier to make immunotherapy agents like Keytruda more effective.

March 9, 2022

Page 1 of 8

Next Page